Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burger

Showing results (311-320 of 338) with videos related to

Pageof 34
Sort By:
The Journal of Antimicrobial Chemotherapy|May 6, 2026
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancyL van der Wekken-Pas, C Hidalgo-Tenorio, J K Rockstroh, et al.
Journal of Crohn'S & Colitis|April 23, 2013
Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel diseaseA J Walsh, M Weltman, D Burger, et al.
Annals of the American Thoracic Society|July 30, 2020
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of CareJoshua D Lee, Charles D Burger, Genecelle B Delossantos, et al.
Mayo Clinic Proceedings|December 19, 2018
Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue DiseasesIsabel Mira-Avendano, Andy Abril, Charles D Burger, et al.
Transplantation Direct|February 12, 2025
The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) ExceptionsKathryn T Del Valle, Dana Kay, Michael J Krowka, et al.
Transplantation Direct|November 18, 2020
Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm HgHilary M DuBrock, James R Runo, Corey J Sadd, et al.
Chest|February 18, 2019
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 2, 2023
Improving Patient Selection and Prioritization for Hospital at Home Through Predictive ModelingSatyabrata Pati, Gina E Thompson, Christopher J Mull, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapyA Tuldrà, C R Fumaz, M J Ferrer, et al.
European Journal of Immunology|July 1, 1997
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malariaR Lucas, P Juillard, E Decoster, et al.
Pageof 34

Showing results (311-320 of 338) with videos related to

Sort By:
Pageof 34
The Journal of Antimicrobial Chemotherapy|May 6, 2026
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancyL van der Wekken-Pas, C Hidalgo-Tenorio, J K Rockstroh, et al.
Journal of Crohn'S & Colitis|April 23, 2013
Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel diseaseA J Walsh, M Weltman, D Burger, et al.
Annals of the American Thoracic Society|July 30, 2020
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of CareJoshua D Lee, Charles D Burger, Genecelle B Delossantos, et al.
Mayo Clinic Proceedings|December 19, 2018
Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue DiseasesIsabel Mira-Avendano, Andy Abril, Charles D Burger, et al.
Transplantation Direct|February 12, 2025
The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) ExceptionsKathryn T Del Valle, Dana Kay, Michael J Krowka, et al.
Transplantation Direct|November 18, 2020
Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm HgHilary M DuBrock, James R Runo, Corey J Sadd, et al.
Chest|February 18, 2019
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 2, 2023
Improving Patient Selection and Prioritization for Hospital at Home Through Predictive ModelingSatyabrata Pati, Gina E Thompson, Christopher J Mull, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapyA Tuldrà, C R Fumaz, M J Ferrer, et al.
European Journal of Immunology|July 1, 1997
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malariaR Lucas, P Juillard, E Decoster, et al.
Pageof 34